Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autism
MedTech
NeuroQure debuts test to ID autism risk at birth
NeuroQure launched a first-of-its-kind test that can identify autism risk at birth, allowing for earlier and more fine-tuned therapies to begin.
Joseph Keenan
Jan 22, 2026 4:50am
Fierce Healthcare
CDC updates website to promote debunked vaccine-autism link
Nov 20, 2025 4:20pm
Ex-FDA leader joins new initiative aiming to protect vaccine use
Apr 24, 2025 1:18pm
NIH-backed screening app detects autism with 88% sensitivity
Oct 3, 2023 11:40am
Beyond Air looks beyond lungs to target nitric oxide in autism
Jun 20, 2023 10:54am
Human brain organoids in mice give view of microglia in autism
May 15, 2023 10:17am